PT2710019T - Processos e intermediários para preparar agentes anti-hiv - Google Patents

Processos e intermediários para preparar agentes anti-hiv

Info

Publication number
PT2710019T
PT2710019T PT127255701T PT12725570T PT2710019T PT 2710019 T PT2710019 T PT 2710019T PT 127255701 T PT127255701 T PT 127255701T PT 12725570 T PT12725570 T PT 12725570T PT 2710019 T PT2710019 T PT 2710019T
Authority
PT
Portugal
Prior art keywords
intermediates
processes
preparing anti
hiv agents
hiv
Prior art date
Application number
PT127255701T
Other languages
English (en)
Portuguese (pt)
Inventor
Hung Chiu Yu Richard
Heath Brown Brandon
P Polniaszek Richard
R Graetz Benjamin
Sujino Keiko
Duc-Phi Tran Duong
Scott Triman Alan
M Kent Kenneth
Pfeiffer Steven
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of PT2710019T publication Critical patent/PT2710019T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44—Amides thereof
    • C07F9/4434—Amides thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4449—Esters with hydroxyaryl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT127255701T 2011-05-19 2012-05-18 Processos e intermediários para preparar agentes anti-hiv PT2710019T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161488133P 2011-05-19 2011-05-19

Publications (1)

Publication Number Publication Date
PT2710019T true PT2710019T (pt) 2017-07-21

Family

ID=46208163

Family Applications (2)

Application Number Title Priority Date Filing Date
PT127255701T PT2710019T (pt) 2011-05-19 2012-05-18 Processos e intermediários para preparar agentes anti-hiv
PT16204289T PT3199537T (pt) 2011-05-19 2012-05-18 Processos e intermediários para preparar agentes anti-hiv

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT16204289T PT3199537T (pt) 2011-05-19 2012-05-18 Processos e intermediários para preparar agentes anti-hiv

Country Status (10)

Country Link
US (5) US8987437B2 (enExample)
EP (3) EP3199537B1 (enExample)
JP (4) JP5951757B2 (enExample)
AR (1) AR086492A1 (enExample)
AU (4) AU2012255029B2 (enExample)
CA (1) CA2835932C (enExample)
ES (2) ES2629913T3 (enExample)
PT (2) PT2710019T (enExample)
TW (1) TWI635093B (enExample)
WO (1) WO2012159047A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3199537B1 (en) 2011-05-19 2018-10-17 Gilead Sciences, Inc. Processes and intermediates for preparing anti-hiv agents
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
US20180085387A1 (en) 2016-09-27 2018-03-29 Gilead Sciences, Inc. Therapeutic compositions for treatment of human immunodeficiency virus
PT3661937T (pt) 2017-08-01 2021-09-24 Gilead Sciences Inc Formas cristalinas de ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofurano-2-il)oxi)metil)(fenoxi)fosforil)-l-alaninato de etil (gs-9131) para tratamento de infeções virais
JP7050165B2 (ja) 2018-02-26 2022-04-07 ギリアード サイエンシーズ, インコーポレイテッド Hbv複製阻害剤としての置換ピロリジン化合物
CN114409706B (zh) * 2019-07-01 2023-11-28 上海医药工业研究院 一种苯基氢膦酸酯及其中间体的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US599431A (en) 1898-02-22 Clothes-wringer
GB835785A (en) * 1956-04-30 1960-05-25 Victor Chemical Works Method of making diaryl phosphites
MX3898E (es) * 1975-12-29 1981-09-10 Monsanto Co Procedimiento mejorado para la preparacion de triesteres de n-fosfonometilglicina
US4198355A (en) * 1977-03-28 1980-04-15 Mobil Oil Corporation Preparation of tertiary alkylphosphorodichloridite derivatives
US5459256A (en) * 1987-04-17 1995-10-17 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Lipophilic, aminohydrolase-activated prodrugs
HU906976D0 (en) 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
HRP20030047B1 (hr) * 2000-07-21 2016-02-26 Gilead Sciences, Inc. Prolijekovi koji su fosfonatni analozi nukleotida i metode njihovog odabira te njihova priprava
TW200408645A (en) 2002-04-26 2004-06-01 Gilead Sciences Inc Non nucleoside reverse transcriptase inhibitors
JP2010535701A (ja) * 2003-04-25 2010-11-25 ギリアード サイエンシーズ, インコーポレイテッド 抗癌ホスホネートアナログ
SG182849A1 (en) 2003-04-25 2012-08-30 Gilead Sciences Inc Antiviral phosphonate analogs
KR20070034119A (ko) * 2004-07-16 2007-03-27 길리애드 사이언시즈, 인코포레이티드 항바이러스 화합물
PT2258376T (pt) 2004-07-27 2019-05-31 Gilead Sciences Inc Análogos fosfonatados de compostos inibidores do vih
AU2006272521A1 (en) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Antiviral phosphonate conjugates for inhibition of HIV
CA2644961A1 (en) * 2006-03-17 2007-09-27 Invista Technologies S.A.R.L. Method for the purification of triorganophosphites by treatment with a basic additive
WO2008100447A2 (en) 2007-02-09 2008-08-21 Gilead Sciences, Inc. Nucleoside analogs for antiviral treatment
BRPI0915878A2 (pt) 2008-07-08 2015-11-03 Gilead Sciences Inc sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
US9790252B2 (en) * 2009-07-01 2017-10-17 Cornell University 2-fluorinated riboses and arabinoses and methods of use and synthesis
EP3199537B1 (en) 2011-05-19 2018-10-17 Gilead Sciences, Inc. Processes and intermediates for preparing anti-hiv agents

Also Published As

Publication number Publication date
US20180079773A1 (en) 2018-03-22
US20160340379A1 (en) 2016-11-24
JP6621772B2 (ja) 2019-12-18
US10196419B2 (en) 2019-02-05
AU2019226278A1 (en) 2019-09-26
AU2016208292B2 (en) 2018-02-22
JP6282295B2 (ja) 2018-02-21
JP2016128459A (ja) 2016-07-14
AU2012255029B2 (en) 2016-04-28
AR086492A1 (es) 2013-12-18
US9783567B2 (en) 2017-10-10
US20190359644A1 (en) 2019-11-28
EP2710019B1 (en) 2017-05-03
JP2019089808A (ja) 2019-06-13
TWI635093B (zh) 2018-09-11
AU2012255029A1 (en) 2013-05-02
US20150203525A1 (en) 2015-07-23
ES2700470T3 (es) 2019-02-15
AU2016208292A1 (en) 2016-08-11
JP2017110025A (ja) 2017-06-22
EP3199537B1 (en) 2018-10-17
WO2012159047A1 (en) 2012-11-22
JP2014516968A (ja) 2014-07-17
EP2710019A1 (en) 2014-03-26
TW201309715A (zh) 2013-03-01
JP5951757B2 (ja) 2016-07-13
US8987437B2 (en) 2015-03-24
US9296779B2 (en) 2016-03-29
EP3450438A1 (en) 2019-03-06
US20120296076A1 (en) 2012-11-22
AU2018200776B2 (en) 2019-10-03
EP3199537A1 (en) 2017-08-02
ES2629913T3 (es) 2017-08-16
CA2835932C (en) 2020-03-24
AU2018200776A1 (en) 2018-02-22
CA2835932A1 (en) 2012-11-22
PT3199537T (pt) 2019-01-17
NZ618939A (en) 2015-11-27

Similar Documents

Publication Publication Date Title
GB201121308D0 (en) Process
ZA201305972B (en) Method for the preparation of biphephos
GB201107072D0 (en) Process
GB201119960D0 (en) Process
SG11201400939YA (en) Process for the preparation of methoxymelonal
IL233654A0 (en) Methods and intermediates for the preparation of pharmaceutical agents
PT3199537T (pt) Processos e intermediários para preparar agentes anti-hiv
GB201121557D0 (en) Process
GB201112051D0 (en) Process
GB201107073D0 (en) Process
GB201218121D0 (en) Process
GB2487402B (en) Scissors
PT2719842E (pt) Reforço para utilização estrutural
GB201112370D0 (en) Process
GB201103092D0 (en) Process
IL229426A0 (en) processes and intermediates
GB2493966B (en) Hair-cutting aid
ZA201408568B (en) Intermediates and processes for preparing compounds
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny
PL2782924T3 (pl) Proces otrzymywania drospirenonu
IL216464A0 (en) Hygaehis scehtep disposable can
AU339427S (en) Medallion
GB201110793D0 (en) Easy carry
GB201208567D0 (en) Process